August 18, 2025
Philadelphia, PA – August 18, 2025 – IntegriChain, a market leader in net revenue optimization technology and insights for the life sciences industry, today announced a strategic leadership evolution within its Product and Technology organization, underscoring the company’s commitment to innovation. Shai Fiss has been appointed as the new Chief AI and Technology Officer (CAIO & CTO), effective August 18, 2025. Concurrently, Brad Burget, the current Chief Technology Officer, will transition to the role of CTO Emeritus. The appointment of Shai Fiss signals a significant step in the company’s strategy to develop and embed creative automation efficiencies across its platform […]
July 2, 2025
Philadelphia, PA, July 2, 2025 – IntegriChain, the leading provider of revenue optimization technology and insights for the pharmaceutical industry, today announced the hiring of Clay Wills. Wilis brings IntegriChain more than a decade of experience in pharmaceutical consulting and advisory, predominantly around 340B, contracting, pricing, and market access issues. “The ever-changing regulatory and pricing landscape poses a tremendous challenge to our customers, and nothing is more troublesome than managing the dynamics of the 340B program” said Bill Roth, Senior Vice President and Managing Partner, Consulting & Advisory of IntegriChain. “Clay brings decades of industry-proven leadership around these complex issues […]
April 15, 2025
Registration is now open for the Access Insights Conference 2025, the only event dedicated to the full spectrum of pharmaceutical commercialization. The conference will take place October 27-29, 2025, at The Mayflower Hotel, Autograph Collection, in Washington, DC.
March 5, 2025
IntegriChain will host the annual RAC Summit, March 27, 2025, in East Brunswick, NJ, sponsored by the Revenue Analytics Collaborative (RAC). The RAC Summit is free to Pharmaceutical manufacturers who wish to learn more about industry challenges and regulations related to pricing and reimbursement, ask questions about commercialization and net revenue optimization, and share best practices amongst industry colleagues.
February 25, 2025
IntegriChain announces the launch of ICyte Commercial Data Suite, a comprehensive platform unifying operational, financial, and commercial data to drive commercial decision-making and go-to-market profitability. The platform combines enterprise data management and analytics to improve both commercial decisioning and go-to-market profitability, solving for the industry’s data fragmentation, quality, and integration gaps.
December 2, 2024
IntegriChain distribution experts will present at Informa’s upcoming Trade & Channel Strategies, December 10-12 in Philadelphia. Conference keynote Bill Roth, Senior Vice President and Managing Partner of the Blue Fin Group, an IntegriChain Company, and Mike Zubey, Senior Vice President, Sales, for IntegriChain have extensive experience and insights tenured in distribution strategies for Pharma manufacturers of all sizes, business stages, and complexity.
November 11, 2024
IntegriChain revenue optimization experts will present at Informa’s upcoming Pharma | Biotech GTN Summit November 18 to 20 in Philadelphia.
October 16, 2024
IntegriChain presented its annual customer awards to Organon, GSK, United Therapeutics, Madrigal Pharmaceuticals, and Boehringer Ingelheim at its record-breaking
thought-leadership conference.
September 10, 2024
Two IntegriChain pharmaceutical pricing and regulatory experts will speak at the Medicaid Drug Rebate Reporting Summit 2024, September 23 to 25 in Chicago, IL.
